Download Citation
Article Source:
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
Lévy Y,
Lacabaratz C,
Ellefsen-Lavoie K,
Stöhr W,
Lelièvre JD,
et al.
(2020)
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
PLOS Pathogens 16(6): e1008522.
https://doi.org/10.1371/journal.ppat.1008522